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Abstract. 
 
Phosphatidylinositol 4,5-bisphosphate
 
(PtdIns[4,5]P
 
2
 
) pools that bind pleckstrin homology 
(PH) domains were visualized by cellular expression of 
 
a phospholipase C (PLC)
 
d
 
 PH domain–green fluores-
cent protein fusion construct and analysis of confocal 
images in living cells. Plasma membrane localization of 
the fluorescent probe required the presence of three 
basic residues within the PLC
 
d
 
 PH domain known to 
form critical contacts with PtdIns(4,5)P
 
2
 
. Activation of 
endogenous PLCs by ionophores or by receptor stimu-
lation produced rapid redistribution of the fluorescent 
signal from the membrane to cytosol, which was re-
 
versed after Ca
 
2
 
1
 
 chelation. In both ionomycin- and ag-
onist-stimulated cells, fluorescent probe distribution 
closely correlated with changes in absolute mass of
PtdIns(4,5)P
 
2
 
. Inhibition of PtdIns(4,5)P
 
2
 
 synthesis by 
quercetin or phenylarsine oxide prevented the relocal-
ization of the fluorescent probe to the membranes after 
Ca
 
2
 
1
 
 chelation in ionomycin-treated cells or during
agonist stimulation. In contrast, the synthesis of the
PtdIns(4,5)P
 
2
 
 imaged by the PH domain was not sensi-
tive to concentrations of wortmannin that had been 
found inhibitory of the synthesis of myo-[
 
3
 
H]inositol–
labeled PtdIns(4,5)P
 
2
 
. Identification and dynamic imag-
ing of phosphoinositides that interact with PH domains 
will further our understanding of the regulation of such 
proteins by inositol phospholipids.
Key words: phosphoinositides • calcium • green fluo-
rescent protein • pleckstrin-homology domain • phos-
pholipase C
 
P
 
leckstrin
 
 homology (PH)
 
1
 
 domains are 
 
z
 
120 amino
acid–long protein modules that were first described
in pleckstrin, the major protein kinase C substrate
in platelets (16). PH domains have since been identified in
several key regulatory proteins with characteristic struc-
tural features that include two orthogonal 
 
b
 
 sheets that
form a sandwich with an 
 
a
 
 helix at the COOH terminus,
and variable loops that create a highly charged surface (11,
16). It has been generally accepted that PH domains pro-
vide a structural basis for the interaction of certain regula-
tory proteins with membranes (23). The search for proteins
that would bind and regulate proteins via PH domains has
generally been unsuccessful, although in some cases, such
as the 
 
b
 
-adrenergic receptor kinase, the region that con-
fers regulation by G protein 
 
bg
 
 subunits overlaps with the
PH domain (28). On the other hand, evidence is accumu-
lating to suggest that PH domains of several proteins in-
teract with membrane phosphoinositides, and that this in-
teraction is critical to the regulation of those proteins (11,
16, 23).
The PH domains of several proteins have been shown to
bind phosphoinositides in a specific manner with micro-
molar affinities in vitro (29, 31). For example, the PH do-
main of phospholipase C (PLC)
 
d
 
1
 
 binds inositol 1,4,5-tris-
phosphate (Ins[1,4,5]P
 
3
 
) and associates with lipid vesicles
containing phosphatidylinositol 4,5-bisphosphate (PtdIns-
[4,5]P
 
2
 
), but only weakly binds other inositol phosphates
and PtdIns(4)P (24). Similarly, the PH domain of the Akt
protein kinase appears to bind PtdIns(3,4)P
 
2
 
 but not Ptd-
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Ins(4,5)P
 
2
 
 (13). However, some PH domains (such as that
of dynamin) show much weaker and less specific interac-
tions with inositol phospholipids (31), raising the question
of whether these binding forces alone are sufficient to an-
chor those proteins to membranes. Whereas in vitro bind-
ing studies have been valuable in determining the ability
of PH domains to associate with inositol phospholipids,
the dependency of the specificity of their binding on lipid
micelle composition and detergent environment (21) em-
phasizes the need to assess these interactions in intact
cells. Another question that is raised by studies on PH do-
main–phosphoinositide interactions is how the binding of
PH domains to the inositide headgroup affects the primary
signaling functions of PtdIns(4,5)P
 
2
 
, particularly its avail-
ability to PLC enzymes or to PtdIns 3 kinases. It is known
that other proteins that bind PtdIns(4,5)P
 
2
 
, such as profi-
lin, greatly impair the ability of PLC enzymes to hydrolyze
this lipid (14).
The present studies were designed to examine whether
specific association of the PLC
 
d
 
 PH domain (PH
 
PLC
 
d
 
)with
PtdIns(4,5)P
 
2
 
 can be exploited to visualize the cellular dis-
tribution of phosphoinositides, that are capable of binding
PH domains in intact cells, and to follow their changes in
real time after stimulation. Our results, obtained using a
fusion protein of the PH
 
PLC
 
d
 
 coupled to the green fluores-
cent protein (GFP), provide imaging of the dynamics of
membrane PtdIns(4,5)P
 
2
 
 pools that interact with PH do-
mains. They also reveal a prominent difference between
the regulation of these pools compared with those labeled
with myo-[
 
3
 
H]inositol.
 
Materials and Methods
 
Materials
 
Angiotensin II (Ang II; human) was obtained from Pheninsula Laborato-
ries, Inc. (San Carlos, CA) and PDGF (recombinant, AB) from Life Tech-
nologies, Inc. (Gaithersburg, MD). Thapsigargin, ionomycin, and 1,2-
bis(2-aminophenoxy)ethane 
 
N
 
,
 
N
 
,
 
N
 
9
 
,
 
N
 
-tetraacetic acid (BAPTA) were
purchased from Calbiochem-Novabiochem, Corp. (La Jolla, CA), and
wortmannin was a gift from Kyowa Hakko Laboratories (Tokyo, Japan).
2,3-Dimercaptopropanol (BAL), phenylarsine oxide, and quercetin were
obtained from Sigma Chemical Co. (St. Louis, MO). Myo-[
 
3
 
H]inositol (68
Ci/mmol) and [
 
3
 
H]inositol-1,4,5-trisphosphate (48 Ci/mmol) was from
Amersham Corp. (Arlington Heights, IL). All other chemicals were of
HPLC or analytical grade.
 
Plasmid Constructs
 
The PH domains of PLC
 
d
 
1
 
 (1–170), Bruton’s tyrosine kinase (1–177), Akt
protein kinase (1–167), and dynamin (508–652) were amplified with the
Advantage Klentaq polymerase mix (CLONTECH Labs, Inc., Palo Alto,
CA) from human cDNAs (marathon cDNA from brain and K562 leuke-
mia cells; CLONTECH Labs, Inc.) with the following primer pairs: 
PLC
 
d
 
: 5
 
9
 
-GGCATGGACTCGGGCCGGGACTTCCTG-3
 
9
 
, 
5
 
9
 
-AAGATCTTCCGGGCATAGCTGTCG-3
 
9
 
;
Btk: 5
 
9
 
-CCAAGTCCTGGCATCTCAATGCATCTG-3
 
9
 
,
5
 
9
 
-TGGAGACTGGTGCTGCTGCTGGCTC-3
 
9
 
; 
Akt: 5
 
9
 
-GTCAGCTGGTGCATCAGAGGCTGTG-3
 
9
 
,
5
 
9
 
-CACCAGGATCACCTTGCCGAAAGTGCC-3
 
9
 
; 
Dyn: 5
 
9
 
-ATGCTCAGCAGAGGAGCAACCAGATG-3
 
9
 
,
5
 
9
 
-GAGTCCACAAGATTCCGGATGGTCTC-3
 
9
 
. 
The amplified products were subcloned into the PGEM-Easy T/A cloning
vector (Promega Corp., Madison, WI) and sequenced with dideoxy se-
quencing (thermosequenase; Amersham Corp.). A second amplification
reaction was performed from these plasmids with nested primers that con-
 
tained restriction sites for appropriate cloning into the pEGFP-N1 (PLC
 
d
 
,
Btk, and Akt) or pEGFP-C1 (dynamin) plasmids (CLONTECH Labs,
Inc.) to preserve the reading frame. Plasmids were transfected into COS-7
cells or NIH-3T3 cells and cell lysates were resolved by SDS-PAGE fol-
lowed by Western blot analysis for the presence of the GFP fusion pro-
teins using a polyclonal antibody against GFP (CLONTECH Labs, Inc.).
Mutations were created in the PH
 
PLC
 
d
 
–GFP fusion plasmid by the
QuickChange™ mutagenesis kit (Stratagene, La Jolla, CA). For practical
purposes, a SalI site was introduced into the PH domain sequence which
changed S34 to a T but this substitution did not change any characteristic
compared with the wild-type protein. All mutations were confirmed by
dideoxy sequencing and the expression of the fusion protein by Western
blot analysis.
 
Transfection of Cells for Confocal Microscopy
 
Cells were plated onto poly-
 
l
 
-lysine–coated 30-mm-diam circular cover
slips at a density of 5 
 
3 
 
10
 
4
 
 cells/dish and cultured for 3 d before transfec-
tion with plasmid DNAs (1 
 
m
 
g/ml) using the Lipofectamine reagent (10
 
m
 
g/ml; Life Technologies, Inc.) and OPTI-MEM (Life Technologies, Inc.).
48 h after transfection cells were washed twice with a modified Krebs-
Ringer solution, containing (mM): NaCl 120, KCl 4.7, CaCl
 
2
 
 1.2, MgSO
 
4
 
0.7, glucose 10, Na-Hepes 10, pH 7.4, and the coverslip was placed into a
chamber that was mounted on a heated stage with the medium tempera-
ture kept at 33
 
8
 
C. Cells were incubated in 1 ml of the Krebs-Ringer buffer
and the stimuli were added in 0.5 ml prewarmed buffer after removing 0.5
ml medium from the cells. Cells were examined in an inverted microscope
under a 40
 
3
 
 oil-immersion objective (Nikon, Inc., Melville, NY) and a
BioRad laser confocal microscope system (MRC-1024) with the Laser-
sharp acquisition software (Bio-Rad Laboratories, Hercules, CA). All pic-
tures presented are original recordings without postacquisition enhancing.
 
Analysis of Inositol Lipids
 
Inositol phospholipids were analyzed from either COS-7 cells transfected
with the AT
 
1a
 
 Ang II receptor together with selected GFP–PH domain fu-
sion constructs, or from untransfected NIH-3T3 cells after labeling with
myo-[
 
3
 
H]inositol for 24 h (COS-7 cells) or 48 h (NIH-3T3 cells) as previ-
ously described (4, 17). [
 
3
 
H]Inositol phosphates were analyzed by HPLC
(17) or, in the COS cell experiments, by Dowex minicolumns. Ptd-
Ins(4,5)P
 
2
 
 mass was determined from NIH-3T3 cells and bovine adrenal
glomerulosa (BAG) cells that were cultured on 12-well plates. After stim-
ulation at 33
 
8
 
C, reactions were terminated with 400 
 
m
 
l ice-cold perchloric
acid (5% final) followed by an acidic lipid extraction (3). Samples were
taken to dryness with N
 
2
 
 stream and were subjected to alkaline hydrolysis
to liberate Ins(1,4,5)P
 
3
 
 from PtdIns(4,5)P
 
2 
 
for quantitation in a radiore-
ceptor assay, essentially as described in Challis (see reference 6) using bo-
vine adrenocortical membranes (15) and [
 
3
 
H]Ins(1,4,5)P
 
3
 
 (Amersham
Corp.).
 
Results
 
Plasma Membrane Localization of the PLC
 
d
 
PH Domain Requires Interaction with PtdIns(4,5)P
 
2
 
Among the known PH domains reported to interact with
PtdIns(4,5)P
 
2
 
, the PH domain of PLC
 
d
 
1
 
 has the highest af-
finity (12). Therefore, we chose this PH domain to create a
fluorescent probe for imaging purposes and fused it to the
NH
 
2
 
 terminus of GFP. Expression of GFP alone showed
no specific cellular localization and was present in the cy-
tosol, as expected from a protein of its size (27 kD) lacking
a localization signal. Addition of the PH domain of PLC
 
d
 
1
 
(1–170) to the GFP (PH
 
PLC
 
d
 
–GFP) was sufficient to local-
ize the construct to the plasma membrane when tran-
siently expressed in various cell types (Fig. 1). A small
amount of fluorescence was always present in the cytosol
and the nucleus, but very little in internal membranes
apart from some vesicular structures that could be mem-
brane invaginations. Although this result was consistent
with binding of the construct to membrane PtdIns(4,5)P
 
2
 
, 
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it did not exclude the possibility of other interaction(s) be-
tween the PH domain and some other membrane compo-
nent(s). Therefore, we mutated each of three critical basic
residues, K30, K32, and R40, within the PH domain that
have been previously found, based on the crystal structure
of the molecule, to contribute to the high affinity binding
of PLC
 
d
 
 to PtdIns(4,5)P
 
2
 
 (12). Each of the three mutations
(K30L, K32L, and R40L) prevented the plasma mem-
brane localization of the construct, whereas mutation of a
non-charged residue in the same region (S34T) had no ef-
fect (Fig. 1). These results indicate that the plasma mem-
brane localization of this fluorescent probe is based on its
interaction with PtdIns(4,5)P
 
2
 
 through the PLC
 
d
 
 PH do-
main, and that the lipid is present predominantly in the
plasma membrane.
 
PLC Activation by Ca
 
2
 
1
 
 Releases the Fluorescent Probe 
from the Plasma Membrane into the Cytosol
 
If the distribution of PH
 
PLC
 
d
 
–GFP truly maps the cellular
PtdIns(4,5)P
 
2
 
 pools, then hydrolysis of these phospholip-
ids by endogenous PLCs should change the distribution of
the fusion protein to report those phosphoinositide changes.
PLC was activated in intact NIH-3T3 cells by treatment
with ionomycin (10 
 
m
 
M) in the presence of external Ca
 
2
 
1
 
(1.2 mM) to allow a large increase in cytosolic Ca
 
2
 
1
 
 con-
centration ([Ca
 
2
 
1
 
]
 
i
 
) with sequential activation of PLC
isozymes (30). As shown in Fig. 2, this manipulation, in-
deed, caused rapid disappearance of fluorescence from the
plasma membrane and its simultaneous appearance in the
cytosol, consistent with PLC-mediated hydrolysis of the mem-
brane PtdIns(4,5)P
 
2
 
 at high [Ca
 
2
 
1
 
]
 
i
 
. Once released into the
cytosol, this 40-kD fusion construct only slowly appeared
in the nucleus. Preincubation of the cells with neomycin
(10 mM) for 10 min to inhibit the hydrolysis of Ptd-
Ins(4,5)P
 
2 
 
(8), completely prevented the release of the flu-
orescent signal from the membranes in the majority
(
 
.
 
90%) of cells (not shown).
Subsequent chelation of external Ca
 
2
 
1
 
 by either BAPTA
or EGTA (2 mM) caused the slow reappearance of the flu-
orescence at the plasma membrane and, most notably, in
some intracellular membrane structures (Fig. 2 
 
B
 
). In
many cells, the first signs of relocalization were the ap-
pearance of bright foci at perinuclear membranes and in
other intracellular structures that eventually translocated
to the plasma membrane (Fig. 2 
 
B). These changes were
considered to reflect the resynthesis of the phosphoinosi-
tide pools as PLC activity declined in concert with the fall-
ing [Ca21]i (see below).
To analyze whether Ca21 release from intracellular stores
without Ca21 influx was sufficient to cause the breakdown
of membrane phosphoinositides that bind PH domains, we
applied ionomycin to the transfected cells in Ca21-free me-
dium. Under these conditions ionomycin failed to evoke a
lipid signal that could be detected by the redistribution of
the fluorescent construct (not shown). To calculate the
concentration of Ca21 that was required to activate Ptd-
Ins(4,5)P2 breakdown in the presence of ionomycin, we ti-
trated extracellular Ca21 in the presence of 2 mM BAPTA
and measured [Ca21]i under identical conditions in Fura-
2–loaded NIH-3T3 cells. Based on these measurements,
the concentration of Ca21 that was required to activate
PtdIns(4,5)P2 hydrolysis (assessed by the release of fluo-
rescence from the membrane into the cytosol) was around
10 mM. The need for relatively high Ca21 to trigger this
process was also indicated by the finding that lower con-
centrations of ionomycin (1 mM), that evoke rapid Ca21
release with consequential activation of the capacitive
Ca21 entry pathway, did not induce translocation of the
fluorescent construct (not shown). Similarly, thapsigargin
(100 nM) or PDGF (25–100 ng/ml), both of which evoked
moderate [Ca21]i increases in NIH-3T3 cells, had no effect
on the distribution of the fusion protein (not shown).
Ca21-induced Changes in Cellular
PtdIns(4,5)P2 Mass Closely Correlate with Plasma 
Membrane Localization of PLCd PH Domain
To examine how the cellular PtdIns(4,5)P2 pool is affected
by the same manipulations that caused the redistribution
of the fusion construct, we analyzed the total mass of this
phospholipid from NIH-3T3 cells after ionomycin treat-
Figure 1. Membrane localization of PLCd PH domain–GFP fu-
sion protein in transfected NIH-3T3 cells. The PH domain of
PLCd (1–170) was fused to the NH2 terminus of the GFP protein
and this construct or its mutants were transiently expressed in
NIH-3T3 cells. Confocal images were obtained in living cells at
338C. For technical reasons, the K30L, K32L, and R40L mutants
also carried the S34T mutation but the latter alone was without
effect on localization. A partial sequence of the PLCd PH domain
containing the first three b strands is shown with the mutated res-
idues indicated by arrows. Residues that form critical contacts
with Ins(1,4,5)P3 (12), are labeled by small squares. Bar, 10 mm.The Journal of Cell Biology, Volume 143, 1998 504
ment and subsequent Ca21 chelation. The total mass of
PtdIns(4,5)P2 in cultured cells was measured by lipid
extraction followed by alkaline hydrolysis to liberate
Ins(1,4,5)P3, which was then quantitated by a radiorecep-
tor assay (6). As shown in Fig. 2 C, ionomycin (10 mM)
caused rapid breakdown of PtdIns(4,5)P2, and upon Ca21
chelation the level of this phospholipid rapidly returned
nearly to its original value within 5 min.
To analyze the correlation between PtdIns(4,5)P2 changes
and the redistribution of fluorescence, we needed to quan-
tify membrane localization. Dividing the fluorescence of
the membrane with that of the adjacent cytosol (values
were taken from line intensity histograms on series of im-
ages) proved to be a useful index of membrane-association
of the construct. As shown in Fig. 2 D, PtdIns(4,5)P2 changes
and membrane localization of the fluorescent construct
correlated remarkably closely during manipulation of in-
tracellular Ca21, except for a clear delay observed in the
plasma membrane reappearance of the fluorescence. This,
however, was preceded by localization of the construct at
intracellular sites (Fig. 2 D), indicating that the earliest
sites of PtdIns(4,5)P2 synthesis are at intracellular mem-
brane compartments.
Ca21-mobilizing Hormones Can Also Initiate
the Breakdown of the PtdIns(4,5)P2 Pool That Binds 
PLCd PH Domain
To investigate whether the PtdIns(4,5)P2 pools that are vi-
sualized by PHPLCd–GFP show any change after agonist
stimulation, we examined the effect of the calcium mobi-
lizing hormone, Ang II, on the redistribution of the fluo-
rescent probe in various cells. The fluorescent construct
was transfected together with the AT1a Ang II receptor
into COS-7 or NIH-3T3 cells, or alone into primary cul-
tures of adrenal glomerulosa cells that express endo-
genous AT1 receptors. Stimulation of the cells with Ang II
caused a rapid release of the fluorescent signal from the
plasma membrane to the cytosol in each of the three cell
types (Figs. 3 and 4). This process was very rapid and, in
contrast to ionomycin stimulation, was only transient with
the construct partially relocalizing to the plasma mem-
brane in spite of the sustained stimulation. Simultaneous
changes in PtdIns(4,5)P2 mass measured in BAG cells
showed again a close correlation between changes in mem-
brane-associated fluorescence and the absolute amounts
of this lipid (Fig. 4, B and C). In contrast to the effects of
ionomycin, the effect of Ang II on PHPLCd–GFP distribu-
tion was still observed in a medium nominally free of Ca21,
although this effect was very short-lived, the fluorescence
being relocalized to the membrane within 2 min (not
shown). These results indicate that stimulation of a G pro-
tein–coupled receptor can cause the breakdown of the Ptd-
Ins(4,5)P2 pool(s) that bind PH domains.
Inhibition of the Resynthesis of PtdIns(4,5)P2
Prevents Relocalization of the PLCd PH Domain to the 
Plasma Membrane
To further examine the interaction between the PLCd PH
domain and the plasma membrane phosphoinositides, we
used inhibitors that have been reported to inhibit the for-
mation of PtdIns(4,5)P2 from PtdIns by inhibiting PtdIns 4
and PtdIns(4)P 5 kinases (34). These inhibitors were tested
Figure 2. Calcium-induced changes in the membrane localiza-
tion of PLCd PH domain–GFP fusion protein and in the absolute
mass of PtdIns(4,5)P2. NIH-3T3 cells were transfected with the
PHPLCd–GFP fusion construct and cells were imaged by confocal
microscopy at 338C. Ionomycin (10 mM) was added at 20 s, and
images taken at 30-s intervals (A). After 5 min, 2 mM BAPTA
was added to the cells and images were taken at the same interval
(B). The numbers indicate the elapsed time in seconds. The
changes in the absolute mass of PtdIns(4,5)P2 was measured in
parallel experiments (C) and compared with the kinetics of redis-
tribution of fluorescence. For this purpose, a fluorescence ratio
was formed from the fluorescence intensities of the plasma mem-
brane (d) or of internal bright spots (s) (Im) relative to that of
cytosol (Icyt) from a line intensity plot at each of the frames from
a number (n 5 8) of cells and these ratios were plotted against
time (D). PtdIns(4,5)P2 levels were expressed as percent of the
control (i.e., before ionomycin stimulation, which was 96.5 6 17
pmol/well, means 6 SEM, n 5 3 duplicate). Bar, 10 mm.Várnai and Balla Imaging Phosphoinositides 505
for their ability to prevent the resynthesis of PtdIns(4,5)P2
after ionomycin treatment and subsequent Ca21 chelation.
As shown in Fig. 5, both quercetin (100 mM) and phenyl-
arsine oxide (PAO; 100 mM) were each able to prevent the
resynthesis of PtdIns(4,5)P2 as measured by the total mass
of this phospholipid. The inhibitory effect of PAO was
completely reversed by DTT, only partially by BAL and
not by b-mercaptoethanol (1 mM each). These same treat-
ments equally affected the relocalization of the fluorescent
probe to the plasma membrane upon Ca21 chelation after
ionomycin treatment: both quercetin and PAO prevented
the reappearance of the fluorescent signal in membranes,
and DTT but not b-mercaptoethanol, were each able to
antagonize the inhibitory effect of PAO (Fig. 5 B). Inter-
estingly, although BAL only partially restored PAO-inhib-
ited PtdIns(4,5)P2 resynthesis, it fully restored the translo-
cation of PHPLCd–GFP. In bovine glomerulosa cells that
were pretreated with quercetin (or with PAO), Ang II in-
duced a more permanent release of the fluorescent con-
struct into the cytosol instead of the transient transloca-
tion observed in control cells, indicating that once the
resynthesis of the PtdIns(4,5)P2 is inhibited, the Ca21-mobi-
lizing agonist causes a more complete degradation of
membrane PtdIns(4,5)P2 (Fig. 4, B and C).
The Resynthesis of PtdIns(4,5)P2 That Binds PH 
Domains Is Not Sensitive to WT Inhibition
Interestingly, high concentrations of wortmannin (WT; 10
mM) shown to inhibit type III PtdIns 4-kinases (27) did not
affect relocalization of the fluorescent construct after Ca21
chelation in ionomycin-treated cells, although it partially
inhibited PtdIns(4,5)P2 resynthesis measured by the mass
assay (Fig. 5). Similarly, 10 mM WT had no effect on the
Ang II–induced transient translocation of the fluorescent
signal (not shown). This result contrasted our previous
finding that the metabolically labeled hormone-sensitive
PtdIns(4,5)P2 pools are maintained by WT-sensitive Ptd-
Ins 4-kinase(s) in several agonist-stimulated cells and that
stimulation of these cells in the presence of 10 mM WT
leads to the depletion of these phosphoinositide pools in
myo-[3H]inositol–labeled cells (27).
These findings suggest that although the myo-[3H]in-
ositol–labeled, agonist-sensitive PtdIns(4,5)P2 pools are
formed by WT-sensitive PtdIns 4-kinase(s), additional
PtdIns(4,5)P2 pools that bind PH domains are synthesized
by WT-insensitive mechanisms that are only inhibited
by less-specific PI kinase inhibitors, such as quercetin or
PAO (34).
Figure 3. Ang II–induced changes in the mem-
brane localization of PLCd PH domain–GFP fu-
sion protein in COS-7 and NIH-3T3 cells. COS-7
(A) and NIH-3T3 cells (B) were transfected with
plasmids encoding the PHPLCd–GFP fusion pro-
tein together with plasmids encoding the rat
AT1a receptor. Confocal images were taken at
every 15 s from cells incubated at 338C. Stimula-
tion by Ang II (1 mM at 20 s) was followed by a
transient translocation of the fluorescent signal
from the membranes to the cytosol. Bar, 10 mm.The Journal of Cell Biology, Volume 143, 1998 506
Relationship between Ca21- and Agonist-responsive 
PtdIns(4,5)P2 Pools That Bind PH Domains
The transient nature of the release of PHPLCd–GFP from
the plasma membrane after Ang II stimulation indicated the
resynthesis of the membrane PtdIns(4,5)P2 during the
action of the hormone. We examined whether such newly
synthesized PtdIns(4,5)P2 having reassociated with PHPLCd–
GFP is available for Ca21-induced hydrolysis. As shown in
Fig. 6 A, ionomycin caused further and complete hydroly-
sis of PtdIns(4,5)P2 in Ang II–stimulated cells as assessed
by the release of PHPLCd–GFP from the membrane. Simi-
lar results were obtained when Ang II action was termi-
nated by the AT1 receptor antagonist, losartan (1025) be-
fore the addition of ionomycin (not shown). The reciprocal
experiment was also performed; bovine glomerulosa cells
expressing PHPLCd–GFP were subjected to one round of
treatment with ionomycin (10 mM) and Ca21 chelation (5
mM EGTA) to allow complete hydrolysis of PtdIns(4,5)P2
and to allow its resynthesis to take place in the presence of
the fluorescent construct. After the removal of ionomycin,
(by several washes with a solution containing BSA), such
cells still showed an Ang II–stimulated redistribution of
fluorescence that did not appear to be significantly differ-
ent from the changes observed in naive cells (Fig. 6 B).
These results indicated that the Ca21- and agonist-respon-
sive pools of PtdIns(4,5)P2 that are available for binding to
PH domains are largely overlapping and that the resynthe-
sized PtdIns(4,5)P2 is still available for agonist-induced hy-
drolysis.
PH Domains Can Inhibit the Agonist-induced 
Hydrolysis of Myo-[3H]inositol–labeled PtdIns(4,5)P2
Since PH domains bind to and therefore cover the inositol
phosphate headgroup of phosphoinositides, they can hin-
der its accessibility and hydrolysis by the agonist-regulated
PLC enzymes. Alternatively, PH domains may interfere
with the membrane localization of the PLC enzymes that
are activated by an agonist. Although all of the known
PLC isoenzymes contain a PH domain, its affinity and
specificity toward inositides has not been analyzed in ev-
ery case (10). To test the possibility that PH domains inter-
fere with agonist-induced Ins(1,4,5)P3 formation from
[3H]inositol-labeled PtdIns(4,5)P2, we overexpressed vari-
ous PH domain–GFP constructs in COS-7 cells together
with the AT1a Ang II receptor and measured Ang II–stim-
ulated [3H]inositol phosphate formation in cells prela-
beled by myo-[3H]inositol. Fig. 7 A shows that PLCd PH
domain greatly inhibited Ang II–stimulated formation of
[3H]inositol phosphates and that other PH domains with
low affinity for PtdIns(4,5)P2, such as that of the Bruton’s
tyrosine kinase or the Akt protein kinase, as well as that of
dynamin (13, 18, 31), showed no similar inhibitory effect.
Fluorescent constructs containing these PH domains did
not show the same membrane localization as those with
the PLCd PH domain (not shown). Also, mutations within
the PH domain of PLCd that prevented its interaction with
PtdIns(4,5)P2, and hence its membrane localization, failed
to inhibit Ang II–induced inositol phosphate production
(Fig. 7 B). The corollary of this finding is that fluorescent
PH domain constructs with high enough affinity to “label”
PtdIns(4,5)P2 pools are most likely to also interfere with
the agonist-sensitive phosphoinositide pools, since their
binding to PtdIns(4,5)P2 impedes their access to the rele-
vant PLC enzymes.
Discussion
The present experiments demonstrate that PH domains
which bind PtdIns(4,5)P2 with high affinity and specificity,
such as that of PLCd1, can be used to visualize certain Ptd-
Ins(4,5)P2 pools in single living cells. Decreasing the affin-
Figure 4. Ang II–induced changes in the membrane localization
of PLCd PH domain–GFP and absolute PtdIns(4,5)P2 mass in
BAG cells. BAG were transfected with the PHPLCd–GFP fusion
construct and examined by confocal microscopy during stimula-
tion with Ang II (1027 M) at 338C. The numbers indicate elapsed
time in seconds. Changes in membrane localization after Ang II
addition were quantitated by forming a fluorescence intensity ra-
tio of the plasma membrane (Ipm) and the cytosol (Icyt) at various
times in control cells (n 5 7), and from cells pretreated with 100
mM quercetin (dashed lines, n 5 5) (B). PtdIns(4,5)P2 levels were
measured in parallel experiments and the values expressed as
percent of control, (i.e., before Ang II stimulation, which was 149 6
16 pmol/well). Means 6 SEM are shown from three experiments
each performed in duplicate. The kinetics of changes in this ratio
again showed close correlation with those of the absolute lipid
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ity of the PH domain by mutation of any one of three basic
residues known to form contacts with the inositol phos-
phate headgroup (12, 35) was sufficient to eliminate mem-
brane localization of the construct. Also, PH domains with
lower affinity for PtdIns(4,5)P2 such as that of the GTP-
binding protein, dynamin, or with different specificity such
as those of the Bruton’s tyrosine kinase and the protein ki-
nase, Akt, did not show the clear plasma membrane local-
ization that was observed with the PLCd PH domain. The
high concentration of the fluorescent probe at the plasma
membrane was consistent with previously established
views that PtdIns(4,5)P2 is most abundant in the plasma
membrane (26). The lack of localization to intracellular
membranes, including the nuclear membrane where a sep-
arate inositide system has been described (7), suggests that
in quiescent cells these membranes either contain only
small amounts of this lipid, or that such pools are not ac-
cessible to the expressed PH domain. Since the interaction
of the PH domain is formed with the inositol phosphate
headgroup of PtdIns(4,5)P2, hydrolysis of the lipid by PLC
is reflected in the release of the fluorescent probe from the
plasma membranes to the cytosol. Such change in localiza-
tion was dramatically demonstrated when endogenous
PLC was activated by Ca21 influx via Ca21 ionophores.
After Ca21 chelation, when PLC activity subsided and Ptd-
Ins(4,5)P2 resynthesis began to take place, the appearance
of bright spots at perinuclear structures preceded the lo-
calization of the fluorescence to the plasma membrane, in-
dicating that some PtdIns(4,5)P2 synthesis also occurs in
intracellular membranes.
This novel methodology, which allowed analysis of the
regulation of cellular PtdIns(4,5)P2 pools from the view-
point of PH domains showed that stimulation of a G pro-
tein–coupled Ca21-mobilizing receptor, the AT1a Ang II
receptor, was also able to activate the hydrolysis of PH do-
main–tagged PtdIns(4,5)P2. In a recent report, Stauffer et
al. (see reference 32) reported that stimulation of PAF re-
ceptors (another G protein–coupled receptor) in a baso-
philic leukaemia cell line also caused a transient transloca-
tion of PLCd PH domain using a similar methodology.
Interestingly, activation of PLCg by PDGF in NIH-3T3
cells (in this study), or by FCeRI stimulation in RBL cells
(33) did not cause any visible change in the distribution of
a PH domain–GFP construct (the PH domain of pleckstrin
was used in reference 33). Whether this reflects the inabil-
ity of PLCg to hydrolyze PtdIns(4,5)P2 when it is covered
by a PH domain remains to be determined.
Overexpression of the PLCd PH domain was also found
to inhibit agonist-induced formation of myo-[3H]inositol–
labeled inositol phosphates in transfected COS-7 cells, and
this effect was closely correlated with the ability of the
construct to localize to the membrane. Similar finding was
presented in a recent report, in which pleckstrin, via its PH
domain, was shown to inhibit [3H]inositol phosphate for-
mation in transfected COS-1 or HEK 293 cells regardless
of the type of PLC that was activated (1). These results
suggest that expressed PH domains also can interfere with
the agonist-regulated PLC activation mechanism, either
by masking the PtdIns(4,5)P2 headgroup from the en-
zyme’s catalytic site or by competing with the PH domains
Figure 5. Inhibition of PtdIns(4,5)P2 synthesis prevents relocalization of the
PLCd PH domain–GFP fusion protein to the plasma membrane. NIH-3T3 cells
were transfected with plasmids encoding the PLCd PH domain–GFP fusion pro-
tein and stimulated at 338C with 10 mM ionomycin for 5 min before addition of
2 mM BAPTA for an additional 5 min. Confocal images (A) were taken from
the cells before stimulation (basal), 5 min after ionomycin addition (iono), and at
the end of 5 min BAPTA treatment (1BAPTA). Cells were also preincubated
with the indicated inhibitors for 5 min before ionomycin addition (WT, 10 mM;
Quer [quercetin], 100 mM; PAO, 100 mM; DTT, 1 mM; BAL, 1 mM; MerOH
[b-mercaptoethanol], 1 mM). PtdIns(4,5)P2 mass (B) was also measured in simul-
taneous experiments in non-transfected NIH-3T3 cells under identical conditions.
The lipid levels were expressed as percent of the absolute control, (i.e., before
ionomycin stimulation and no treatment with inhibitors, which was 91 6 7.2 pmol/well). Means 6 SEM are shown from three experi-
ments each performed in duplicate. Bar, 10 mm. The Journal of Cell Biology, Volume 143, 1998 508
of the PLC enzymes to inhibit their localization to the
membranes. These results also emphasize that the PLC ac-
tivity detected in cells is greatly influenced by membrane
components that interact with phosphoinositides, and that
the use of cell-free systems and artificial substrates cannot
reveal this aspect of PLC regulation.
An important finding of the present study was the in-
ability of WT (at mM concentrations that inhibit type III
PtdIns 4 kinases) to prevent the resynthesis of the Ptd-
Ins(4,5)P2 pools available for binding of the PLCd PH do-
main in both ionomycin- and agonist-stimulated cells. The
same treatment completely prevented the synthesis of
myo-[3H]inositol–labeled PtdIns(4,5)P2 in Ang II–stimu-
lated adrenal glomerulosa cells (27), and also blocks the
resynthesis of [3H]PtdIns(4,5)P2 after chelation of Ca21 in
ionomycin-treated NIH-3T3 cells (Varnai, P., and T. Balla,
unpublished observations). This finding raised the possi-
bility that the agonist-sensitive myo-[3H]inositol–labeled
PtdIns(4,5)P2 pools are not completely identical to those
that are imaged by the fluorescent PH domain of PLCd, al-
though both respond to agonist stimulation. Heterogene-
ity of phosphoinositide pools have been described earlier
in a few reports. These studies indicated that some of the
metabolically labeled PtdIns and PtdIns(4,5)P2 pools are
not sensitive to agonist stimulation (22) and conversely,
some PtdIns(4,5)P2 that is not labeled metabolically is still
subject to PLC-mediated hydrolysis (20). The existence
of a metabolically hyperactive hormone-sensitive Ptd-
Ins(4,5)P2 pool, however, could not be substantiated (25).
Our results indicate that, unlike the [3H]inositol-labeled
PtdIns(4,5)P2 pools, the PtdIns(4,5)P2 pool(s) that bind
PH domains are not synthesized by WT-sensitive type III
PtdIns 4 kinases. The highly abundant, tightly membrane-
bound type II PtdIns 4 kinase (5), which is not sensitive to
Figure 6. Availability of newly synthesized
PtdIns(4,5)P2 to repeated stimulation of
phospholipase C in BAG cells. BAG cells
were transfected with plasmids encoding the
PLCd PH domain–GFP fusion protein. (A)
Cells were stimulated with Ang II (1027 M)
for 5 min before addition of 10 mM ionomy-
cin, and then 5 mM EGTA. In some experi-
ments, losartan (1025 M, an AT1 receptor an-
tagonist) was added for 10 min to terminate
Ang II action before the administration of
ionomycin (not shown). (B) Cells were stimu-
lated with 10 mM ionomycin and, immedi-
ately after the redistribution of fluorescence,
5 mM EGTA was added to remove Ca21. Af-
ter 10 min, cells were washed twice with incu-
bation medium containing 5% BSA to reduce
ionomycin, and then incubated in normal me-
dium (containing 1.2 mM Ca21) for an addi-
tional 10 min before stimulation with Ang II
(1027 M). Bar, 10 mm.Várnai and Balla Imaging Phosphoinositides 509
even high concentrations of WT (9) is a good candidate for
synthesizing the inositides that bind PH domains. Clearly,
more experiments will be required to find the explanation
for the apparent discrepancy between the regulation of
myo-[3H]inositol–labeled and PH domain–imaged Ptd-
Ins(4,5)P2.
An additional possibility to be considered in under-
standing the current results is that the Ins(1,4,5)P3 that is
formed after agonist stimulation competes for the PH do-
main of PLCd (and of other proteins), and contributes to
the release of these proteins from the plasma membrane,
especially when PtdIns(4,5)P2 levels are decreasing. Such
competition by Ins(1,4,5)P3 with PtdIns(4,5)P2 for the PH
domain of PLCd has been demonstrated and also found to
inhibit the catalytic efficiency of the enzyme (2, 19). Since
the only known major source of Ins(1,4,5)P3 is Ptd-
Ins(4,5)P2, this competing effect of Ins(1,4,5)P3 would dis-
tort the imaging results if there were substantial amounts
of Ins(1,4,5)P3 formed from PtdIns(4,5)P2 pools that did
not bind PH domains in their initial steady-state before
stimulation. Nevertheless, this is an open possibility and a
better assessment of such a displacing effect of Ins(1,4,5)P3
requires additional studies with GFP-fused PH domains.
In summary, the present studies demonstrate that iso-
lated PH domains fused to the GFP are capable of recog-
nizing phosphoinositides in living cells with remarkable
specificity. These interactions allow visualization of the
spatiotemporal changes in phosphoinositides at the single
cell level. Analysis of cellular PtdIns(4,5)P2 with this
method reveals that the pools that bind PH domains my
not be identical to those that can be metabolically labeled
with myo-[3H]inositol. Studies on the receptor-mediated
control of the PtdIns(4,5)P2 pools that bind PH domains
will help to understand the manner in which phospho-
inositides regulate various signaling processes via protein
PH domains.
The skillful technical work of Ms. Y. Zhang is greatly appreciated.
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